If you made any changes in Pure these will be visible here soon.

Personal profile


Dr Vilija G. Jokubaitis (B. Com/B.Sci (Hons), PhD), is a Senior Research Fellow in the Department of Neuroscience, Central Clinical School at Monash University.  She leads the Neuroimmunology and Multiple Sclerosis Biomarker, Genomics, and Prognostics Group. She is a clinical and translational neuroscientist with
skills in molecular medicine and biostatistics. Her research interest lies specifically, in the intersection between biology and clinical outcomes research. The overarching aim of her research is to improve the prediction of Neuroinflammatory disease outcomes (with a focus on MS) in individuals, with the ultimate goal of informing patient management and treatment individualisation.


Research interests

Dr Jokubaitis' research themes fall under three broad umbrellas:

  1. Identification of genetic and epigenetic signals associated with disease outcomes and disease states
  2. Integration of biological (biomarker, genetic) and environmental data with clinical outcomes data to inform prognostic modelling
  3. Interrogation of the effects of pregnancy and hormones on disease outcomes in neuroinflammatory conditions

External positions

Honorary Senior Research Fellow, Alfred Health

Feb 2018 → …

Honorary Senior Research Fellow, The University of Melbourne

22 Jan 2018 → …

Honorary Research Fellow, The Royal Melbourne Hospital

2011 → …


  • Neuroimmunology
  • Multiple Sclerosis (MS)
  • Central Nervous System
  • Neuroscience
  • Genetics
  • Epigenetics
  • Biomarkers
  • Biostatistics
  • Epidemiology
  • Outcomes Research
  • Environment
  • Women's Health
  • Pharmacogenomics

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2018 2020

Research Output 2008 2018

  • 30 Article
  • 2 Review Article
  • 1 Chapter (Book)
  • 1 Comment / Debate

Association of Inflammation and Disability Accrual in Patients with Progressive-Onset Multiple Sclerosis

Hughes, J., Jokubaitis, V., Lugaresi, A., Hupperts, R., Izquierdo, G., Prat, A., Girard, M., Duquette, P., Grand'maison, F., Grammond, P., Sola, P., Ferraro, DI., Ramo-Tello, C., Trojano, M., Slee, M., Shaygannejad, V., Boz, C., Lechner-Scott, J., Van Pesch, V., Pucci, E. & 12 othersSolaro, C., Verheul, F., Terzi, M., Granella, F., Spitaleri, D., Alroughani, R., Jun, J. K., Fambiatos, A., Van Der Walt, A., Butzkueven, H., Kalincik, T. & for the MSBase Study Group, 1 Jan 2018, (Accepted/In press) In : JAMA Neurology. 9 p.

Research output: Contribution to journalArticleResearchpeer-review

Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis

Kalincik, T., Jokubaitis, V., Spelman, T., Horakova, D., Havrdova, E., Trojano, M., Lechner-Scott, J., Lugaresi, A., Prat, A., Girard, M., Duquette, P., Grammond, P., Solaro, C., Grand’Maison, F., Hupperts, R., Prevost, J., Sola, P., Ferraro, D., Terzi, M., Butler, E. & 9 othersSlee, M., Kermode, A., Fabis-Pedrini, M., McCombe, P., Barnett, M., Shaw, C., Hodgkinson, S., Butzkueven, H. & on behalf of the MSBase Study Group, Oct 2018, In : Multiple Sclerosis. 24, 12, p. 1617-1626 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Genotype and Phenotype in Multiple Sclerosis—Potential for Disease Course Prediction?

Jokubaitis, V. G., Zhou, Y., Butzkueven, H. & Taylor, B. V., 1 Jun 2018, In : Current Treatment Options in Neurology. 20, 6, 18.

Research output: Contribution to journalReview ArticleResearchpeer-review

Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis

Signori, A., Izquierdo, G., Lugaresi, A., Hupperts, R., Grand’Maison, F., Sola, P., Horakova, D., Havrdova, E., Prat, A., Girard, M., Duquette, P., Boz, C., Grammond, P., Terzi, M., Singhal, B., Alroughani, R., Petersen, T., Ramo, C., Oreja-Guevara, C., Spitaleri, D. & 22 othersShaygannejad, V., Butzkueven, H., Kalincik, T., Jokubaitis, V., Slee, M., Fernandez Bolaños, R., Sanchez-Menoyo, J. L., Pucci, E., Granella, F., Lechner-Scott, J., Iuliano, G., Hughes, S., Bergamaschi, R., Taylor, B., Verheul, F., Edite Rio, M., Amato, M. P., Sajedi, S. A., Majdinasab, N., Van Pesch, V., Sormani, M. P. & Trojano, M., 1 Apr 2018, In : Multiple Sclerosis. 24, 5, p. 642-652 11 p.

Research output: Contribution to journalArticleResearchpeer-review

Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMS

Lorscheider, J., Jokubaitis, V. G., Spelman, T., Izquierdo, G., Lugaresi, A., Havrdova, E., Horakova, D., Trojano, M., Duquette, P., Girard, M., Prat, A., Grand'Maison, F., Grammond, P., Pucci, E., Boz, C., Sola, P., Ferraro, DI., Spitaleri, D., Lechner-Scott, J., Terzi, M. & 9 othersVan Pesch, V., Iuliano, G., Bergamaschi, R., Ramo-Tello, C., Granella, F., Oreja-Guevara, C., Butzkueven, H., Kalincik, T. & on behalf of the MSBase Study Group, 5 Sep 2017, In : Neurology. 89, 10, p. 1050-1059 10 p.

Research output: Contribution to journalArticleResearchpeer-review